Lower risk for MCI and dementia also seen with moderate, high cardiovascular health in those with high polygenic risk score.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.

Topline results were announced from two phase 3 trials evaluating combination regimens containing belzutifan (Welireg) for the treatment of renal cell carcinoma.

Belimumab is linked to a reduced risk for all-cause mortality compared with azathioprine, methotrexate, and mycophenolate among patients with nonrenal SLE.

Akebia Therapeutics has decided not to initiate a clinical trial assessing vadadustat in patients with late-stage CKD not on dialysis.

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Topline data were announced from a phase 3 trial evaluating obinutuzumab in adults with systemic lupus erythematosus on standard therapy.

United States real-world studies highlight the importance of controlling lupus nephritis to improve patient prognosis.

(HealthDay News) — The U.S. Food and Drug Administration (FDA) has recalled over half a million bottles of a widely prescribed blood pressure medication, prazosin hydrochloride, because of concerns ...

The Interaktor app was well-received by patients undergoing radiotherapy for prostate cancer seeking to monitor and manage their symptoms.The effectiveness of the Interaktor app was evaluated in a ...

(HealthDay News) — Adolescents whose parents had two or more opioid prescriptions have a more than doubled risk for persistent opioid use, according to a study published online Oct. 23 in PLOS ...

Michael Liu, M.D., from Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cross-sectional study to examine the percentage of U.S. health care professionals (HCPs) sponsored ...